- Service Name
Debiopharm
- Industry
Biopharmaceutical, drug development, oncology, infectious diseases
- Main Value Proposition
Debiopharm aims to improve patient outcomes and quality of life by developing tomorrow's standard of care in biopharmaceuticals.
- Description
Debiopharm is an independent biopharmaceutical company based in Switzerland focused on developing innovative solutions to cure cancer and infectious diseases. The company is dedicated to improving patient quality of life through drug development, manufacturing, and digital health investments.
- Key Features
Innovative drug development for oncology and bacterial infections; Comprehensive drug manufacturing capabilities; Investment in digital health and smart data start-ups; Commitment to corporate responsibility and societal contribution
- Use Cases
Debiopharm's services are most valuable in scenarios involving the development of new treatments for cancer and infectious diseases, as well as in the investment in digital health technologies.
- Competitive advantages
Strong commitment to innovation in drug development; Diverse portfolio including drug manufacturing and digital health investments; Established history and expertise in the biopharmaceutical industry since 1979
- Strengths
Debiopharm's main strengths include its long-standing experience in the industry, a dedicated team of professionals, and a robust commitment to improving patient care through innovative solutions.
- Positioning
Debiopharm positions itself as a leader in biopharmaceutical innovation, focusing on patient-centric solutions and cutting-edge research.
- Audience
The target users include healthcare professionals, patients seeking innovative treatments, and investors interested in biopharmaceutical advancements.
- CTA
Discover
- Tags
biopharmaceuticals
drug development
digital health
oncology
- Tagline
Establishing tomorrow's standard of care
- Tone of Voice
Professional, innovative, compassionate
- Differentiation
Debiopharm's unique business model focuses on in-licensing innovative compounds and developing them into medicines for out-licensing, which sets it apart from traditional pharmaceutical companies.
- Brand Positioning
Debiopharm's brand identity is centered around innovation, quality of life improvement, and a commitment to corporate responsibility.
- Founded
1979-01-01
- Founders
Rolland-Yves Mauvernay